Degussa attains sole ownership of start-up Proligo LLC and invests additional $ 18 million to support future growth
28-Aug-2001 -
Degussa AG, Dusseldorf, announced today that its subsidiary Degussa Corp, NJ, will acquire the outstanding
49 percent interest in Proligo LLC from Gilead Sciences, Inc. (Nasdaq: GILD) to gain 100 percent ownership of Proligo. At the same time Degussa announced that it has provided $ 18 million ...
acids
active pharmaceutical ingredients
biotechnology
+9